A Pilot Study of 0.4% Povidone-Iodine Nasal Spray to Eradicate SARS-CoV-2 in the Nasopharynx.

Sirijatuphat, Rujipas; Leelarasamee, Amorn; Puangpet, Thanapat; Thitithanyanont, Arunee

Sirijatuphat, Rujipas; Leelarasamee, Amorn; Puangpet, Thanapat; Thitithanyanont, Arunee.

Afiliação

Sirijatuphat R; Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Leelarasamee A; Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Puangpet T; Faculty of Medicine, Siam University, Bangkok, Thailand.
Thitithanyanont A; Samut Sakhon Hospital, Samut Sakhon, Thailand.

Infect Drug Resist ; 15: 7529-7536, 2022.

Article em En | MEDLINE | ID: mdl-36575672

Palavras-chave

COVID-19; SARS-CoV-2; nasopharyngeal swab; povidone iodine; viral culture; viral eradication

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Infect Drug Resist Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Tailândia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google